Acute Intermittent Porphyria

Acute Intermittent Porphyria is a genetic metabolic disorder. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Generally, it is characterized by a deficiency of the enzyme porphobilinogen deaminase. DelveInsight’s “Acute Intermittent Porphyria Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Acute Intermittent Porphyria, historical and forecasted epidemiology asContinue reading “Acute Intermittent Porphyria Market: Industry Analysis, Epidemiology, Pipeline Therapies, Companies and Forecast by DelveInsight”